Clinical Trial

Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Valves: a Prospective Randomized Open-label Multicentric Trial Enriched With Historic Controls.

Study acronym: CIRCUP 2
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Boys with posterior urethral valves (PUV) are at increased risk of developing febrile urinary tract infections (fUTIs). As shown in the CIRCUP trial, circumcision plus antibiotic prophylaxis reduces the risk of FUTIs compared with antibiotic prophylaxis alone. This multicenter randomised controlled trial prospectively compares circumcision alone with circumcision plus antibiotic prophylaxis for the prevention of fUTIs in boys with PUV, enriched with external historical data from the CIRCUP trial)
Trial Details
NCT Number NCT07527442
Lead Sponsor University Hospital, Bordeaux
Conditions Posterior Urethral Valves
Enrollment 72 participants
Start Date 2026-04-13
Primary Completion 2032-04-13 (estimated)
Study Completion 2032-04-13 (estimated)
Updated on ClinicalTrials.gov 2026-04-14